Home Casteddu.com FAQ My Amedeo About Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Anemia

  Free Subscription


Articles published in Am J Kidney Dis

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    June 2009
  1. BUEMI M , Campo S, Bolignano D
    Erythropoietin and cancer: an old risk.
    Am J Kidney Dis. 2009;53:1102.
    PubMed     Related articles   


    March 2009
  2. KALANTAR-ZADEH K , Lee GH, Miller JE, Streja E, et al
    Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients.
    Am J Kidney Dis. 2009.
    PubMed     Related articles    Abstract available


  3. VAZIRI ND
    Thrombocytosis in EPO-Treated Dialysis Patients May Be Mediated by EPO Rather Than Iron Deficiency.
    Am J Kidney Dis. 2009.
    PubMed     Related articles   


    February 2009
  4. MICHAEL M , Elliott EJ, Craig JC, Ridley G, et al
    Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials.
    Am J Kidney Dis. 2009;53:259-72.
    PubMed     Related articles    Abstract available


    January 2009
  5. MESSANA JM , Chuang CC, Turenne M, Wheeler J, et al
    Association of Quarterly Average Achieved Hematocrit With Mortality in Dialysis Patients: A Time-Dependent Comorbidity-Adjusted Model.
    Am J Kidney Dis. 2009.
    PubMed     Related articles    Abstract available


    December 2008
  6. CROWTHER M , Radwi G
    Erythropoietin-stimulating agents: ongoing concerns with safety.
    Am J Kidney Dis. 2008;52:1039-41.
    PubMed     Related articles   


  7. KAUFMAN JS
    Racial differences in erythropoietin responsiveness.
    Am J Kidney Dis. 2008;52:1035-8.
    PubMed     Related articles   


  8. PIZZI LT
    Economic considerations in a changing anemia environment.
    Am J Kidney Dis. 2008;52.
    PubMed     Related articles    Abstract available


  9. COYNE DW
    Introduction to "A road map for intravenous iron and anemia management: preparing for the future".
    Am J Kidney Dis. 2008;52.
    PubMed     Related articles   


  10. SINGH AK
    The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?
    Am J Kidney Dis. 2008;52.
    PubMed     Related articles    Abstract available


  11. KAPOIAN T
    Challenge of effectively using erythropoiesis-stimulating agents and intravenous iron.
    Am J Kidney Dis. 2008;52.
    PubMed     Related articles    Abstract available


  12. COYNE DW
    A comprehensive vision for intravenous iron therapy.
    Am J Kidney Dis. 2008;52.
    PubMed     Related articles    Abstract available


    November 2008
  13. AUERBACH M
    Ferumoxytol as a new, safer, easier-to-administer intravenous iron: yes or no?
    Am J Kidney Dis. 2008;52:826-9.
    PubMed     Related articles   


    October 2008
  14. ROZEN-ZVI B , Gafter-Gvili A, Paul M, Leibovici L, et al
    Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: Systematic Review and Meta-analysis.
    Am J Kidney Dis. 2008.
    PubMed     Related articles    Abstract available


  15. LITTLEWOOD TJ
    Normalization of hemoglobin in patients with CKD may cause harm: but what is the mechanism?
    Am J Kidney Dis. 2008;52:642-4.
    PubMed     Related articles   


    September 2008
  16. SINGH A , Patel T, Hertel J, Bernardo M, et al
    Safety of Ferumoxytol in Patients With Anemia and CKD.
    Am J Kidney Dis. 2008.
    PubMed     Related articles    Abstract available


  17. LACSON E JR , Rogus J, Teng M, Lazarus JM, et al
    The Association of Race With Erythropoietin Dose in Patients on Long-term Hemodialysis.
    Am J Kidney Dis. 2008.
    PubMed     Related articles    Abstract available


  18. FERVENZA FC , Croatt AJ, Bittar CM, Rosenthal DW, et al
    Induction of Heme Oxygenase-1 and Ferritin in the Kidney in Warm Antibody Hemolytic Anemia.
    Am J Kidney Dis. 2008.
    PubMed     Related articles    Abstract available


  19. CHAN MR , Thomas CP, Torrealba JR, Djamali A, et al
    Recurrent Atypical Hemolytic Uremic Syndrome Associated With Factor I Mutation in a Living Related Renal Transplant Recipient.
    Am J Kidney Dis. 2008.
    PubMed     Related articles    Abstract available


  20. COYNE DW
    The TREAT study answers a question, not the question.
    Am J Kidney Dis. 2008;52:626-7.
    PubMed     Related articles   


    August 2008
  21. STREJA E , Kovesdy CP, Greenland S, Kopple JD, et al
    Erythropoietin, Iron Depletion, and Relative Thrombocytosis: A Possible Explanation for Hemoglobin-Survival Paradox in Hemodialysis.
    Am J Kidney Dis. 2008.
    PubMed     Related articles    Abstract available


  22. COUZI L , Contin-Bordes C, Marliot F, Sarrat A, et al
    Inherited deficiency of membrane cofactor protein expression and varying manifestations of recurrent atypical hemolytic uremic syndrome in a sibling pair.
    Am J Kidney Dis. 2008;52:e5-9.
    PubMed     Related articles    Abstract available


    July 2008
  23. EPSTEIN FH
    Hypokalemia during sickle cell crisis.
    Am J Kidney Dis. 2008;52:196.
    PubMed     Related articles   


  24. ABARRATEGUI-GARRIDO C , Melgosa M, Pena-Carrion A, de Jorge EG, et al
    Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome.
    Am J Kidney Dis. 2008;52:171-80.
    PubMed     Related articles    Abstract available


    June 2008
  25. YUSUF B , McPhedran P, Brewster UC
    Hypocalcemia in a Dialysis Patient Treated With Deferasirox for Iron Overload.
    Am J Kidney Dis. 2008;.
    PubMed     Related articles    Abstract available


    May 2008
  26. WOLFE RA , Port FK
    Evaluation of dialysis performance measures.
    Am J Kidney Dis. 2008;51:867-8.
    PubMed     Related articles   


  27. COYNE DW
    Relative mortality and epoetin alpha dose among hemodialysis patients.
    Am J Kidney Dis. 2008;51:866-7.
    PubMed     Related articles   


  28. COTTER DJ , Thamer M, Zhang Y
    Relative mortality and epoetin alpha dose in hemodialysis patients.
    Am J Kidney Dis. 2008;51:865.
    PubMed     Related articles   


    April 2008
  29. MCFARLANE SI , Chen SC, Whaley-Connell AT, Sowers JR, et al
    Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Am J Kidney Dis. 2008;51.
    PubMed     Related articles    Abstract available


  30. BOYER O , Noel LH, Balzamo E, Guest G, et al
    Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.
    Am J Kidney Dis. 2008;51:671-7.
    PubMed     Related articles    Abstract available


    March 2008
  31. EDEY MM , Mead PA, Saunders RE, Strain L, et al
    Association of a factor H mutation with hemolytic uremic syndrome following a diarrheal illness.
    Am J Kidney Dis. 2008;51:487-90.
    PubMed     Related articles    Abstract available


  32. GARG AX , Salvadori M, Okell JM, Thiessen-Philbrook HR, et al
    Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.
    Am J Kidney Dis. 2008;51:435-44.
    PubMed     Related articles    Abstract available


  33. PFEFFER MA
    Critical missing data on erythropoiesis-stimulating agents in CKD: first beat placebo.
    Am J Kidney Dis. 2008;51:366-9.
    PubMed     Related articles   


    February 2008
  34. JAITLY M , Mohan S, Park CM, Anderson HL, et al
    Hypokalemia during sickle cell crises apparently due to intermittent mineralocorticoid excess.
    Am J Kidney Dis. 2008;51:319-25.
    PubMed     Related articles   


    January 2008
  35. GAWEDA AE , Jacobs AA, Aronoff GR, Brier ME, et al
    Model predictive control of erythropoietin administration in the anemia of ESRD.
    Am J Kidney Dis. 2008;51:71-9.
    PubMed     Related articles    Abstract available


    December 2007
  36. KLINGER M , Arias M, Vargemezis V, Besarab A, et al
    Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.
    Am J Kidney Dis. 2007;50:989-1000.
    PubMed     Related articles    Abstract available


    November 2007
  37. SPOLTER YS , Seliger SL, Zhan M, Hsu VD, et al
    The relationship between dialysis performance measures: adequacy and anemia management.
    Am J Kidney Dis. 2007;50:774-81.
    PubMed     Related articles    Abstract available


    October 2007
  38. HOODA A , Kim S, Kanna B
    Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.
    Am J Kidney Dis. 2007;50:687-8.
    PubMed     Related articles   


    September 2007

  39. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target.
    Am J Kidney Dis. 2007;50:471-530.
    PubMed     Related articles   


  40. LAZARUS JM , Hakim RM
    Dialysis facility ownership and epoetin dosing in hemodialysis patients: a dialysis provider's perspective.
    Am J Kidney Dis. 2007;50:366-70.
    PubMed     Related articles   


  41. COHEN JT , Neumann PJ
    Dialysis facility ownership and epoetin dosing in hemodialysis patients: a medical economic perspective.
    Am J Kidney Dis. 2007;50:362-5.
    PubMed     Related articles   


  42. MACDOUGALL IC
    Dialysis facility ownership and epoetin dosing in hemodialysis patients: a view from Europe.
    Am J Kidney Dis. 2007;50:358-61.
    PubMed     Related articles   


  43. WEINER DE , Levey AS
    Dialysis facility ownership and epoetin dosing in hemodialysis patients: an overview.
    Am J Kidney Dis. 2007;50:349-53.
    PubMed     Related articles   


    June 2007
  44. FISHBANE S
    Iron management in nondialysis-dependent CKD.
    Am J Kidney Dis. 2007;49:736-43.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: